Cellectar Biosciences (CLRB) Q2 2024 Earnings
CLRB·Reported August 13, 2024·Before market open
Diluted EPS came in at $-0.73, missed the $-0.23 consensus by $0.50.
Diluted EPS
$-0.73missed by $0.50
Consensus: $-0.23
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about Cellectar Biosciences's Q2 2024 earnings report.
Cellectar Biosciences (CLRB) reported Q2 2024 earnings on August 13, 2024 before market open.
Cellectar Biosciences reported diluted EPS of $-0.73 for Q2 2024.
EPS missed the consensus estimate of $-0.23 by $0.50.